Seattle Genetics reported $341.41M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Amgen AMGN:US $ 5097M 208M
Astellas Pharma 4503:JP Y 263018M 894M
Bayer BAYN:GR 5.89B 414M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Bristol Myers Squibb BMY:US $ 9333M 81M
Clovis Oncology CLVS:US $ 28.07M 0.88M
Daiichi Sankyo 4568:JP Y 178489M 428M
Eisai 4523:JP Y 122837M 36807M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Exelixis EXEL:US $ 316.55M 53.74M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
Glaxosmithkline GSK:US $ 6255M 682M
Insmed INSM:US $ 36.57M 2.04M
Karyopharm Therapeutics KPTI:US $ 37.1M 15.64M
MacroGenics MGNX:US 14M 16.74M
Merk MRK:US $ 10098M 1738M
Moderna Inc MRNA:US 4.25B 643M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Novartis NOVN:VX 9.52B 21M
Pfizer PFE:US $ 14163M 2178M
Puma Biotechnology PBYI:US $ 35.97M 5.45M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Seattle Genetics SGEN:US $ 341.41M 31.02M
Takeda 4502:JP Y 569023M 139316M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M
YTE INCY:US $ 778.52M 105.44M